"Risk of Metabolic Complications in Patients with Solid Tumors Treated with mTOR inhibitors: Meta-analysis." by Sungyub Lew

Selected Works of Ronald Chamberlain, MD, MPA, FACS

Follow Contact

Article

Risk of Metabolic Complications in Patients with Solid Tumors Treated with mTOR inhibitors: Meta-analysis.

Anticancer Research (2016)

Sungyub Lew, Saint Barnabas Medical Center
Ronald S Chamberlain, Rutgers University
Ronald S Chamberlain, University of the West Indies
Ronald S Chamberlain, Saint Barnabas Medical Center

Link

Disciplines

Pharmacology,
Medicine and Health Sciences,
Oncology and
Internal Medicine

Publication Date

April 1, 2016

Citation Information

Sungyub Lew, Ronald S Chamberlain, Ronald S Chamberlain and Ronald S Chamberlain. "Risk of Metabolic Complications in Patients with Solid Tumors Treated with mTOR inhibitors: Meta-analysis." Anticancer Research Vol. 36 Iss. 4 (2016) p. 1711 - 1718
Available at: http://works.bepress.com/ronald-chamberlain/32/